Vaccines against human enteric bacterial pathogens.
The development of vaccines against enteric bacterial pathogens presents a challenge because of the large number of pathogens capable of causing disease and the requirement to induce immunity that is effective in the gut. A new generation of enteric vaccines based either on live or non-living antigens delivered orally or by injection are reaching the clinic in the early phases of evaluation. However, considerable technical barriers have to be overcome before these vaccines reach the general population.
Dougan
Gordon
G
Centre for Molecular Microbiology and Infection, Department of Biological Sciences, Imperial College of Science, Technology and Medicine, London, UK.
Huett
Alan
A
Clare
Simon
S
D000284:Administration, Oral; D001428:Bacterial Vaccines / Q000008:administration & dosage; D004756:Enterobacteriaceae Infections / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D018928:Immunity, Mucosal; D015164:Vaccines, Inactivated
D001428:Bacterial Vaccines; D015164:Vaccines, Inactivated